Abstract: Bone tissue engineering is a complex process that requires concerted functions of biomaterials, cells, and bioactive growth factors. A porous nano-hydroxyapatite (nHA)/collagen (Col)-bone morphogenetic protein (BMP)-9/gelatin microsphere (GM) scaffold was fabricated by a combination of blending, crosslinking, and freeze-drying technologies. The nHA/Col-BMP-9/GM scaffold was well manufactured with a three-dimensional structure and had good mechanical properties. Rat bone marrow mesenchymal stem cells (BMMSCs) were isolated and cultured in vitro, and then identified by flow cytometry. An indirect Cell Counting Kit-8 assay demonstrated that the scaffolds favored BMMSC proliferation, indicating their cytocompatibility. In vitro, BMMSCs were seeded onto the nHA/Col-BMP-9/GM scaffolds to mimic a natural microenvironment. Scanning electron microscopy observation and adhesion rate determination were performed to evaluate the adherence and growth of BMMSCs on the composite scaffolds. Cells cultured in the scaffolds tended to maintain good morphology, attachment, and proliferation, confirming that the scaffolds were biocompatible and showed no cytotoxicity in vitro. Alkaline phosphatase expression was examined to assess the effect of the composite scaffolds on the osteogenic differentiation of rat BMMSCs. The results revealed that the nHA/Col-GM scaffolds, especially the BMP-9-loaded nHA/Col-GM scaffolds, significantly promoted the osteogenic differentiation of BMMSCs. For in vivo determination, acute toxicity, pyrogenic, and implantation tests were performed and verified that the composite scaffolds possessed excellent biocompatibility. This novel biocompatible scaffold has good application prospects for bone repair and regeneration.
Introduction
Tissue engineering (TE), an emerging multidisciplinary scientific field, focuses on the therapeutics of tissue regeneration. An ideal regeneration process for impaired bone tissue by TE depends on an appropriate cell source, biocompatible scaffold, and biomimetic culture environment. Bone marrow mesenchymal stem cells (BMMSCs) have been most commonly used in bone tissue engineering (BTE) applications not only for their self-renewal ability and multiple differentiation potential, but also because they are abundant and relatively easy to harvest 1) . From this point of view, BMMSCs can be selected as candidate cells for loading into scaffolds for improved construction of tissue-engineered bone and investigation of biocompatibility 2) . A crucial factor for BTE is the selection of a proper biomedical material that is cell-friendly, causes no or minimal immunological rejection, and can promote cell migration, adhesion, proliferation, and differentiation. For this purpose, a variety of biomaterials, broadly classified into naturally derived and synthetic materials, have been used as substrates for scaffolds in TE. Hydroxyapatite (HA), which has a calcium-to-phosphate ratio of 1.67, is one of the inorganic elements composing the native bone extracellular matrix (ECM) 3) . Nano-hydroxyapatite (nHA), which mimics the nanostructure of natural bone, has attracted increasing attention because of its crystal structure and compressive strength. It also has other important features, including its similar chemical composition to bone and good mechanical performance. In recent studies, nHA has been combined with various compounds to yield composite scaffolds that acted as better promoters of cell proliferation and osteogenesis 4) . Collagen, the most abundant protein in mammalian ECM, is an attractive molecule for BTE applications because of its high hydrophilicity and good biocompatibility. Although collagen offers the indicated benefits, its use for BTE is limited by its rapid degradation rate and poor mechanical properties. Nevertheless, when collagen is combined with nHA, the composite material is expected to satisfy the requirements of an ideal bone substitute 5) . It has become clear that growth factors (GFs) and scaffolds play essential biological roles for the augmentation of stem cell-based therapeutics. GFs have been widely used in BTE to stimulate natural repair processes and induce bone regeneration 6) . Bone morphogenetic proteins (BMPs) are members of the transforming growth factor-β superfamily, which contains signaling molecules and important factors that regulate cells during developmental processes [7] [8] . BMP-9, the most potent osteogenic factor, has direct effects on the expression of osteogenic markers such as alkaline phosphatase (ALP) and osteocalcin. However, the short half-life of this protein can limit its local delivery and decrease its efficacy for bone defect repair in vivo 9) . Thus, it is of prime importance to develop sustained released-based approaches that can solve these issues.
Gelatin microspheres (GMs), created from gelatin by crosslinking, are particularly well-known release carriers that show excellent hydrophilicity. GMs have been extensively used for medical and industrial purposes owing to their excellent biocompatibility and good sustained release properties [10] [11] [12] [13] .
To provide a more appropriate biocompatible environment for BTE, a three-dimensional nHA/Col-BMP-9/GM scaffold was fabricated by a method involving high-speed stirring and freeze-drying. Collagen and nHA were chosen as the basic matrices while GMs were loaded to generate a sustained release system. To investigate the suitability of the scaffold for biological applications, the physical properties and proliferative and osteogenic activities were determined in vitro, while the acute toxicity and pyrogenic activity were evaluated in vivo.
Materials and Methods

Materials
nHA (Emperor Nano Material Co., Ltd, Nanjing, China) and collagen I (ColI; Corning Inc., Corning, NY, USA) were chosen as the basic matrices for synthesis of the nHAC-B9/GM composite scaffold. BMP-9 was purchased from PeproTech (Rocky Hill, NJ, USA). Fetal bovine serum (FBS), phosphate-buffered saline (PBS), and alpha minimum essential medium (αMEM) were purchased from GE Healthcare Life Sciences Hyclone Laboratory (South Logan, UT, USA). Penicillin/ streptomycin and trypsin-EDTA were purchased from GE Healthcare Life Sciences Hyclone Laboratory (South Logan, UT, USA). BMP-9 ELISA kits were purchased from Cusabio Biotechnology Company (Wuhan, China). Cell counting kit-8 (CCK-8) and alkaline phosphatase (ALP) kits were purchased from Nanjing Jiancheng Bioengineering Institute (Nanjing, China).
Scaffold fabrication
Type A gelatin was used to fabricate BMP-9-loaded GMs by an emulsion-solvent diffusion method 14) . Briefly, a 25 wt% gelatin solution prepared in 30 ml of liquid paraffin was subjected to crosslinking in glutaraldehyde aqueous solution at 4°C for 24 h, followed by quenching with glycine. The resulting GMs were washed with distilled water, and freeze-dried at −80°C (Alpha 1-2 LD Plus, Christ, Hamburg, Germany). BMP-9 pre-dissolved in PeproTech protein solution was encapsulated in the crosslinked GMs by adsorption. nHA powder was homodispersed in a collagen solution produced by dissolving freeze-dried collagen I (Col I) in 50 mmol/L acetic acid, and the final ratio (nHA:Col I) was determined at 7:3 [15] [16] . BMP-9/GMs were added and gently stirred at low temperature to produce homogeneously dispersed microspheres throughout the nHA-Col I blended solution, resulting in a final BMP-9 concentration of 100 ng/ml in the nHA/Col-BMP-9/GM scaffold. The resulting solution was poured into the pores of a polytetrafluoroethylene mold, frozen at −20°C overnight, and lyophilized at −80°C for 72 h.
Characterization of nHAC-B9GM scaffolds
After gold coating, the microstructure of the nHA/Col-BMP-9/GM scaffolds was evaluated by scanning electron microscopy (SEM) using an S-4800 microscope (Hitachi, Tokyo, Japan). The diameters of the pores were measured using Image J software (National Institutes of Health, Bethesda, MD, USA).
The porosity of the fabricated scaffolds was examined by a liquid displacement method in ethyl alcohol (EtOH), using the following equation: Porosity (%)=(V1-V3)/(V2-V3) ×100%, where V1 is the primary volume of EtOH, V2 is the total volume of EtOH and the scaffold after saturation, and V3 is the residual EtOH volume after removing the EtOH-impregnated scaffold.
The compressive strength of the obtained scaffolds was determined using a Universal Material Testing Machine (E1000; Instron, Norwood, MA, USA). Scaffolds with a diameter of 5.00 mm and height of 10.00 mm were evaluated by application of a 100-N load cell at a crosshead speed of 1 mm/min.
In vitro BMP-9 release
The level of BMP-9 encapsulated in the nHA/Col-BMP-9/GM scaffolds was investigated using a BMP-9 ELISA kit (Cusabio Biotechnology Company, Wuhan, China). First, a standard sample and 2 ml of PBS (pH 7.4) were placed in a container and incubated at 37°C. At preset time points, the supernatant was collected for storage at −20°C until analysis, and the same volume was replaced in the container. Finally, the cumulative concentrations of BMP-9 were determined with the ELISA kit according to the manufacturer's instructions and a release curve was drawn.
Isolation, culture, andidentification of BMMSCs
Rat BMMSCs were isolated and cultured using previously reported protocols 17) . Briefly, rats were euthanized by cervical dislocation. The bilateral femurs and tibias were removed aseptically and rinsed in PBS containing penicillin and streptomycin. The bone marrow tissue was quickly flushed out with complete α-MEM medium (α-MEM containing 100 U/ml penicillin, 100 U/ml streptomycin, and 10% FBS). The primary cells were obtained by centrifugation at 800 rpm for 5 min, resuspended in complete α-MEM medium, and maintained at 37°C in a humidified 5% CO 2 incubator. The cell medium was replaced after 24 h to remove the non-adherent cells. When the BMMSCs reached 80-90% confluence, they were detached with trypsin and passaged at a ratio of 1:3. After digestion and centrifugation, the density of BMMSCs at passage 3 was adjusted to 1×10 6 cells/100 µl with pre-cooled PBS. A cell suspension was then prepared and analyzed by flow cytometry (FACSCanto II; BD Biosciences, Franklin Lakes, NJ, USA) to detect BMMSC-related markers (CD44, CD29, CD45, CD34). Samples incubated with PBS served as the negative controls and the experiments were repeated three times.
CCK-8 assay
A cytotoxicity assay was carried out by an indirect contact method according to ISO 10993-12 18) . The scaffolds were immersed in five times their weight of standard culture medium for 72 h at 37°C in a humidified atmosphere with 5% CO 2 . After centrifugation, the obtained supernatant was used as extract-conditioned medium in a cytotoxicity test on BMMSCs. The cells were seeded in 96-well plates at approximately 1×10 4 cells/well and incubated for 24 h to allow attachment. The culture medium was removed and replaced with extract-conditioned medium.
After incubation for 1, 3, 5 and 7 days, the cells were detected by a Cell Counting Kit (CCK)-8 Kit and the absorbance was measured at 450 nm using a microplate reader (Infinite M200; Tecan, Salzburg, Austria).
Cell attachment evaluation
Prior to cell seeding, aseptic scaffolds were placed in a 24-well culture plate and immersed in complete α-MEM medium overnight at 37°C. BMMSCs at a density of 2×10 4 cells/ml were seeded onto the sterilized scaffolds to prepare cell-scaffold constructs and cultured at 37°C with 5% CO 2 . The numbers of BMMSCs were counted at 1, 3, and 6 h after seeding, and the adhesion rate was measured by the following equation: Adhesion rate (%)=n1/n2×100%, where n1 indicates the num-ber of adhered cells and n2 indicates the number of seeded cells.
To visualize the cell morphology, the samples were gently rinsed with PBS after 72 h of incubation and fixed with 2.5% glutaraldehyde in water overnight at 4°C. The samples were then sequentially dehydrated in a series of ethanol concentrations (30%, 50%, 70%, 80%, 90%, 100%) for 20 min each and air-dried. After sputter-coating with gold, the morphology and adhesion of BMMSCs on the scaffolds were observed by SEM.
ALP expression assay
The cell-scaffold constructs were incubated for 1, 4, 7, and 10 days at 37°C in a humidified 5% CO 2 incubator, and the medium was changed every other day. After the cultures, the specimens were determined for ALP activity at pre-designed time points. Briefly, adherent cells were rinsed with PBS and separated from the scaffolds by treatment with 1% Triton X-100 at 4°C. Next, 30 µl of cell suspension was lysed and added with buffer solution and matrix liquid. After incubation at 37°C for 15 min, a chromogenic agent was added to the mixture and the optical density (OD) was measured at 520 nm.
In vivo acute toxicity, pyrogenic, and implantation tests
For the acute toxicity test, 20 healthy mice were randomly divided into two groups of 10 mice. Toxicity was evaluated by a test protocol ISO Acute Injection Test and approved by the Subcommittee on Research and Animal Care of China Medical University. The mice were housed in plastic cages and maintained under standard laboratory facilities with free access to water and food. The animals were injected with preheated extracts of nHA/Col-GM samples at a dose of 1 ml/kg. Mortality, body weight, and manifestations of toxicity were recorded for each mouse immediately after injection and at 4, 24, 48, and 72 h post-injection. Subchronic toxicity was evaluated at 14 days post-injection by harvesting the main organs (kidney, lung, liver, heart, spleen) for hematoxylin and eosin (H&E) staining.
For the pyrogenic test, a total of 9 healthy New Zealand White rabbits weighing approximately 2.8 kg were provided by the Experimental Animal Center of China Medical University. The animals were immobilized and measured for rectal temperature in advance. Extracts of nHA/ Col-GM samples that had been preheated to 38.5°C were injected via the marginal ear vein at 10 ml/kg, and the rectal temperature was measured and recorded at 1, 2, and 3 h post-injection. According to the protocol for ISO 10993-12 18) , samples were considered non-pyrogenic if the rise in body temperature was below 0.6°C and the whole rise in rectal temperature was below 1.4°C for each animal.
For the subcutaneous implantation test, 12 male Sprague-Dawley rats (8 weeks of age; weight: 220-300 g) were provided by the Experimental Animal Center of China Medical University. After anesthesia by injection of chloral hydrate (10%; 3 ml/kg), a 10-mm longitudinal incision was made in the back skin of the animals and the nHA/Col-GM sample was implanted subcutaneously. The animals were euthanized by cervical dislocation under anesthesia with isoflurane at designated time points (7, 14, 21 , and 28 days) after surgery. Tissue samples were obtained and immediately fixed in 4% paraformaldehyde for immunohistochemical staining. The samples were embedded in paraffin and cut into serial sections at 6-µm thickness. The obtained sections were investigated for expression of the universal macrophage marker CD68 using an anti-CD68 antibody (Abcam, Cambridge, MA, USA), because detection of CD68 can indicate inflammatory reactions around the nHA/Col-GM samples.
Statistical analysis
Statistical analyses were conducted with SPSS 17.0 statistical software (SPSS Inc., Chicago, IL, USA). All data were presented as mean ± SD. Student's t-test was used for pairwise comparisons. For all experiments, values of p<0.05 were considered significant.
Results
Characterization of scaffolds
Determination of the physical properties, at least surface morphology and mechanical properties, can indicate whether a composite scaffold satisfies the requirements for BTE [19] [20] [21] [22] . The nHA/Col-GM scaffolds exhibited a cylindrical shape and good flexibility with a rough white surface (Fig. 1A) . The GMs prepared by the emulsion-solvent diffusion technique had a pale yellow appearance with a regular spherical shape (Fig. 1B) . On SEM images, a well-developed porous structure consisting of interconnected pores was observed for the three-dimensional composite scaffolds, with a large number of nHA particles deposited on the surface of the collagen matrix structure ( Fig. 2A, B and C) . The appearance of apertures with no clear fixed direction and scattered GMs dispersed in the nHA/Col pore wall were observed, and the pore size distribution in the nHA/Col-GM scaffolds ranged from 110 to 190 µm. The porosity of the composite scaffolds was up to 83.62 in the EtOH displacement determination. The compressive strength of the scaffolds was 3.48 MPa and the elastic modulus was 0.64 MPa ( Table 1) . The in vitro release profile of BMP-9 from the delivery system was Table 1 . Physical characterizations of nHA/Col-GM scaffold determined by its cumulative amount. The amounts of in vitro BMP-9 release from the nHA/Col-BMP-9/GM scaffolds were measured with an ELISA kit. Release of BMP-9 encapsulated in GMs showed an initial burst release on day 1 followed by a tapered release behavior until a plateau was reached after 13 days. In vitro release of BMP-9 from the scaffolds was continuously detected to assume an almost linear sustained release up to 21 days, with the total release amount reaching 95.59 ± 2.82% (Fig. 3) .
BMMSC culture andidentification
Within the first few hours after inoculation, there were a large number of suspended red blood cells in the culture plates with only a few primary BMMSCs attached to the wall (Fig. 4A) . After 48 h, BMMSCs began to stretch and gradually deformed to spindle-shaped or polygonal cells (Fig. 4B) . At 72 h, the numbers of BMMSCs adhering to the wall had substantially expanded and cell colonies began to form. After passaging, the adherent cells exhibited high proliferation rates with spindle or triangle shapes (Fig. 4C) .
Flow cytometry was used to identify specific surface markers on the obtained BMMSCs. The results revealed strongly positive expression for mesenchymal stem cell surface markers CD44 and CD29 at 97.7% and 100%, respectively. By contrast, the positive expression of hematopoietic cell-related surface markers included CD34 and CD45 at 1.9% and 0.8%, respectively. These findings proved that the cells met the flow cytometry standards for BMMSCs (CD44 and CD29 >90%, CD45 and CD34 <10%) (Fig. 5) .
In vitro cytotoxicity and osteogenic inductionanalyses
As scaffolds can impact cell viability, cytotoxicity detection was carried out by the CCK-8 assay to evaluate the biocompatibility. The OD values in all groups were enhanced with increasing incubation time (Fig.  6C) . These results suggested that the BMMSCs exhibited good proliferative activities in the presence of extracts from the composite scaffolds. In addition, the BMMSCs retained a polygonal morphology and strong refraction after incubation in 100% extracts from the scaffolds for 3 days, consistent with the findings for the control group (Fig. 6A, B) .
After direct cell inoculation on the composite scaffolds, the adhesion rate was evaluated to investigate the interactions between the cells and the biomaterials. During the first 3 h of culture, the nHA/Col-GM and nHA/Col-BMP-9/GM groups were more conducive to cell adhesion than the control group (p<0.05). However, the scaffolds containing BMP-9 exhibited similar cell adhesion profiles to the nHA/Col-GM scaffolds, with no significant difference in the results (p>0.05). After 6 h of incubation, the cell adhesion in the nHA/Col-GM group was higher than that in the control group, but lower than that in the nHA/Col-BMP-9/GM group (p<0.05) (Fig. 7) .
To better understand the effects of the composite scaffolds on the cell morphology and distribution, SEM observations were employed at 3 days post-seeding. The micrographs revealed abundant cells that spread well and invaded the open pores of the scaffolds (Fig. 8) . Furthermore, the cells were tightly attached to the scaffolds and stretched to form a polygonal or elongated morphology, indicating that the porous composite scaffolds were beneficial for the growth and attachment of BMMSCs in vitro.
ALP expression is an early marker of osteogenic differentiation of progenitor cell populations. To demonstrate the scaffolds could release a bioactive GF and promote osteogenic differentiation of BMMSCs, ALP assays were conducted on days 1, 4, 7, and 10 after cell seeding on the scaffolds. After 1 day of culture, there were no significant differences in ALP activity among the groups (p>0.05). Starting from day 4, the OD values in the scaffold groups displayed significantly higher ALP activities than the untreated control group (p<0.05). Furthermore, the ALP activity in the nHA/Col-BMP-9/GM group was remarkably increased compared with that in the nHA/Col-GM group (p<0.05) (Fig. 9) . These findings indicated that the porous scaffolds could protect the encapsulated GF and effectively activate the surrounding BMMSCs. 
In vivo biocompatibility assessment
To further detect the biocompatibility of the composite scaffolds in vivo, an acute injection test was performed by injecting mice with leachates of the scaffolds. All animals survived during the course of the analysis and remained in good health without adverse events such as reduced eating, paralysis, or respiratory inhibition. Moreover, none of the mice lost in excess of 10% of their body weight during the observation period (Table 2) . After 14 days, the mice were euthanized and their main organs were examined on histological sections. Gross observations revealed no abnormalities in the animals. Histomorphological assessments of H&E-stained sections revealed no pathological changes in the five main organs (kidney, lung, liver, heart, spleen) (Fig. 10) .
The results of pyrogenic tests at preset time points showed that after injection with extracts of the scaffolds, the maximum increase in body temperature for a single rabbit was 0.3°C, being no higher than the national standard of 0.6°C. The whole rise in temperature was 0.5°C, and thus compliant with the national standard (total temperature rise <1.4 °C). These findings suggested that the scaffolds did not induce pyrogenic reactions (Table 3) .
In the subcutaneous implantation test, all 12 rats recovered well without any abnormal signs of exudation or infection at the surgical implant site and survived until the designated study endpoints. Immunohistochemical staining revealed that infiltration of CD68 + mononuclear cells occurred during the first 7 days after surgery and the number of positively stained cells increased with prolongation of the implantation period up to 14 days (Fig. 11A, B) . However, from 21 days after implantation, the number of CD68 + mononuclear cells was much lower compared with the previous time points (Fig. 11C) . Furthermore, obvious signs of scaffold degradation were observed with accumulation of positively stained cells around the scaffold networks (Fig. 11D ).
Discussion Bone tissue is a dynamic system that plays a vital role in the body and is continuously remodeled on a day-to-day basis [23] [24] . Diseases and traumatic injuries, including osteoarthritis, tumors, and osteoporosis, can lead to bone damage and impair normal bone functions 25) . TE, a rapidly evolving field for tissue regeneration and replacement, has changed the current clinical approach to the treatment of impaired organs that cannot self-regenerate. Cells, biomaterials, and bioreactors are critical issues that require 30) . An ideal scaffold should possess good mechanical performance to tolerate the load of the biological environment and have an appropriate structure with an interconnected network to mimic the function of the ECM [31] [32] .
In this study, nHA and Col I were selected as the basic matrices for fabrication of the nHA/Col-BMP-9/GM scaffolds, and BMP-9-loaded GMs were included in the scaffolds. The ECM of native bone is a fibrous composite structure arising from the assembly of collagen fibrils and HA nanocrystals 33) . It was reported that nHA particles, as a kind of bioceramic, can effectively promote the growth and adherence of human osteoblast-like cells 34) . Collagen, the most abundant protein in mammals, exhibits excellent absorbability and biocompatibility, and slight immunogenicity 35) . In our indirect cytotoxicity assessment using the CCK-8 assay, the nHA/Col-BMP-9/GM groups showed no decrease in cell number or metabolic activity compared with the control group, thereby verifying the biocompatibility of the composite scaffolds. Adhesion rate analyses confirmed that BMMSCs grew well with evidently higher cell adhesion rates on the scaffolds than on culture plates, which may arise from the porous and 3D structures of the scaffolds. After 6 h of incubation, the results showed increased cell adhesion in the nHA/ Col-BMP-9/GM group compared with the nHA/Col-GM group. This may arise from the higher number of vacuum freeze-drying times required to fabricate the nHA/Col-GM scaffolds loaded with BMP-9 compared with the nHA/Col-GM scaffolds. After lyophilization, the solvents in the material sublimated and formed a number of small holes, which may have led to changes in the surface performance of the materials [36] [37] [38] .
Moreover, SEM images showed that the surfaces of the scaffolds were rough with various deposited nHA particles, which may also be associated with the increase in cell attachment. In recent years, BMP-9 has been reported to show the highest potency for modulating osteogenesis among the 15 types of human BMPs. Fujioka-Kobayashi et al. demonstrated that demineralized freeze-dried bone allografts or biphasic calcium phosphate combined with rhBMP-9 induced higher osteoblast differentiation compared with rhBMP-2 39) . In the present study, the nHA/Col-GM scaffolds were loaded with BMP-9 to prepare composites for improvement of osteoinductivity.
To further investigate the effects of the composite scaffolds on the osteogenic differentiation of BMMSCs in vitro, we conducted ALP assays. The results indicated that nHA/Col-GM induced remarkably increased osteogenic activity compared with the control group. Furthermore, BMMSCs cocultured with nHA/Col-BMP-9/GM showed even greater potential for osteogenic differentiation compared with nHA/Col-GM alone. These results demonstrated the importance of BMP-9 as an osteogenic agent for increased BMMSC differentiation capacity. It was reported that biomaterials can affect tissue responses and consequently modulate foreign body reactions 40) . Biomaterials may lead to intense inflammatory responses and tissue irritation, which can culminate in delayed tissue healing 41) . Considering the in vivo safety and biocompatibility of the composite scaffolds, acute toxicity and pyrogenic tests were conducted according to the International Standard ISO-10993: Biological Evaluation of Medical Devices Part 1. The results confirmed that the scaffolds caused neither abnormalities nor pathological damage to the main organs of the experimental animals. Researchers have reported that immune responses are vital factors that can affect biomaterial-mediated regeneration of bone tissue 42) . To further determine the suitability of the composite scaffolds for BTE, immunohistochemical staining of the macrophage marker CD68 was conducted after scaffold implantation.
The results indicated that the composite scaffolds degraded with increasing implantation period and the degradation products did not lead to obvious tissue irritation. The data presented herein verified that the fabricated nHA/Col-BMP-9/GM scaffolds possessed porous 3D structures together with the desired mechanical strength and good biocompatibility in vitro and in vivo. Taken together, we can reasonably conclude that application of the nHA/Col-BMP-9/GM scaffolds could be a promising strategy for BTE to treat bone defects.
